Neurology & Neuroscience - Hydroxytyrosol from olives shows new promise as a brain-protective compound
View as a Web Page
News Medical
 
  Neurology & Neuroscience Neurology & Neuroscience logo  
  The latest neurology news from News Medical  
 

iPSCs Redefining Disease Modeling in Neuroscience ResearchiPSCs Redefining Disease Modeling in Neuroscience Research

Induced pluripotent stem cells (iPSCs) are driving new advances in neurodegenerative disease research. This eBook highlights how iPSCs and 3D cultures enable more accurate modeling of Alzheimer’s and Parkinson’s, improve neuronal characterization, and support scalable drug discovery—offering ethical, human-relevant insights that accelerate progress toward understanding and treating brain disorders.

Download the eBook
 
   Hydroxytyrosol from olives shows new promise as a brain-protective compoundHydroxytyrosol from olives shows new promise as a brain-protective compound
 
This review highlights hydroxytyrosol's role as a neuroprotective agent, activating key pathways for mental and vascular health through olive-derived compounds.
 
   Football hits leave lasting brain changesFootball hits leave lasting brain changes
 
Recent MRI research reveals how repeated football head impacts reshape brain structures, offering insights into chronic traumatic encephalopathy (CTE) risk.
 
 Gut bacteria in toddlers may influence anxiety and depression years later
 
Gut bacteria in toddlers may influence anxiety and depression years laterThis study links childhood gut microbiome to brain connectivity, highlighting its role in internalizing symptoms like anxiety and depression later in life.
 
 
 How Animals Use The Same Balance Control System
 
How Animals Use The Same Balance Control SystemA study uncovers shared mechanisms of foot placement in walking, highlighting the role of feedforward-feedback systems in stable locomotion across species.
 
 
 Mount Sinai receives $4.5 million grant to investigate neural mechanisms underlying bipolar disorder
 
Mount Sinai receives $4.5 million grant to investigate neural mechanisms underlying bipolar disorderThe Icahn School of Medicine at Mount Sinai is pleased to announce it has received a three-year, $4.5 million grant from BD2: Breakthrough Discoveries for thriving with Bipolar Disorder to investigate the neural mechanisms underlying bipolar disorder and pioneer novel neuromodulation-based treatment strategies.
 
 
 Exploring the gut-brain-immune axis in neurodegeneration
 
Exploring the gut-brain-immune axis in neurodegenerationNeurodegenerative diseases (NDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), represent a growing global health burden, particularly in aging populations.
 
 
 Mutation in NAMPT Gene Found to Cause Rare Neurological Disease
 
Mutation in NAMPT Gene Found to Cause Rare Neurological DiseaseAn international research team, led by Shinghua Ding at the University of Missouri, has identified a previously unknown genetic disease that affects movement and muscle control.
 
 
 Study Reveals How Blood Vessels Drive Neuron Movement in the Brain
 
Study Reveals How Blood Vessels Drive Neuron Movement in the BrainResearchers have discovered how newly created neurons depend on blood flow in the adult brain to travel from their site of origin to their final location.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025